Advertisement
Advertisement
Trending on Urology Times
1
Prostate Cancer Working Group 4: What urologists need to know
2
The MIBC Referral Gap: Why Half of Patients Miss Perioperative Therapy
3
Matthew Galsky, MD, on how EV/pembrolizumab is redefining the MIBC treatment paradigm
4
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
5